Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon γ and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection.
Anti-Retroviral Agents
/ therapeutic use
CD4-Positive T-Lymphocytes
/ metabolism
CD8-Positive T-Lymphocytes
/ metabolism
Cell Movement
Chemokine CCL20
/ metabolism
Chemokine CXCL10
/ metabolism
Chemokine CXCL11
/ metabolism
Chemokine CXCL9
Chemokines, CC
/ metabolism
Cytokines
/ metabolism
HIV Infections
/ metabolism
Humans
Interferon-gamma
/ metabolism
Interleukin-18
/ metabolism
Intestinal Mucosa
/ metabolism
Intestine, Small
/ metabolism
Receptors, CXCR3
/ metabolism
Th1 Cells
/ metabolism
Th17 Cells
/ metabolism
CCL20
CCL25
CD8
CXCR3
HIV-1
IFN-γ
IL-18
Th1
gut
Journal
The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675
Informations de publication
Date de publication:
31 07 2019
31 07 2019
Historique:
received:
16
07
2018
accepted:
14
03
2019
pubmed:
19
3
2019
medline:
22
5
2020
entrez:
19
3
2019
Statut:
ppublish
Résumé
The restoration of CD4+ T cells, especially T-helper type 17 (Th17) cells, remains incomplete in the gut mucosa of most human immunodeficiency virus type 1 (HIV-1)-infected individuals despite sustained antiretroviral therapy (ART). Herein, we report an increase in the absolute number of CXCR3+ T cells in the duodenal mucosa during ART. The frequencies of Th1 and CXCR3+ CD8+ T cells were increased and negatively correlated with CCL20 and CCL25 expression in the mucosa. In ex vivo analyses, we showed that interferon γ, the main cytokine produced by Th1 and effector CD8+ T cells, downregulates the expression of CCL20 and CCL25 by small intestine enterocytes, while it increases the expression of CXCL9/10/11, the ligands of CXCR3. Interleukin 18, a pro-Th1 cytokine produced by enterocytes, also contributes to the downregulation of CCL20 expression and increases interferon γ production by Th1 cells. This could perpetuate an amplification loop for CXCR3-driven Th1 and effector CD8+ T cells recruitment to the gut, while impairing Th17 cells homing through the CCR6-CCL20 axis in treated HIV-1-infected individuals.
Identifiants
pubmed: 30880342
pii: 5382280
doi: 10.1093/infdis/jiz123
doi:
Substances chimiques
Anti-Retroviral Agents
0
CCL20 protein, human
0
CCL25 protein, human
0
CXCL10 protein, human
0
CXCL11 protein, human
0
CXCL9 protein, human
0
CXCR3 protein, human
0
Chemokine CCL20
0
Chemokine CXCL10
0
Chemokine CXCL11
0
Chemokine CXCL9
0
Chemokines, CC
0
Cytokines
0
IL18 protein, human
0
Interleukin-18
0
Receptors, CXCR3
0
Interferon-gamma
82115-62-6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
830-840Informations de copyright
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.